FTH
Faeth Therapeutics, Inc.
+0.39 (+1.14%)34.63USD58.2K成交股數895M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 9.2M | 19.7M | 2.3M | 2.7M | 3.5M | 2.8M | 3.2M | 3.2M | 3.8M | 3.9M | 5.4M | 5.8M |
| 營業利益 | −18.4M+153% | −171M+1962% | −4.9M-38% | −5.2M-33% | −7.3M-17% | −8.3M+7% | −7.8M-23% | −7.8M-29% | −8.7M | −7.7M | −10.2M | −11.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −16.0M+133% | −170M+2091% | −4.6M-37% | −4.9M-31% | −6.9M-14% | −7.8M+9% | −7.3M-23% | −7.1M-30% | −8.0M | −7.1M | −9.4M | −10.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -2.84-48% | -131.45+975% | -3.62-37% | -3.91-31% | -5.45+1603% | -12.23+4268% | -5.77+1761% | -5.69+1624% | -0.32 | -0.28 | -0.31 | -0.33 |
| 稀釋股數 | 5.6M | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M | 25.0M | 25.5M | 30.5M | 30.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 26.9M | 152M | 10.6M | 12.6M | 9.9M | 10.0M | 19.1M | 11.9M | 11.0M | 11.3M | 10.2M | 8.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 189M | 205M | 27.6M | 31.8M | 38.3M | 45.4M | 53.3M | 59.8M | 66.7M | 81.7M | 89.6M | 108M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 9.6M | 14.2M | 4.6M | 4.5M | 6.3M | 7.0M | 7.5M | 7.6M | 8.2M | 10.7M | 10.4M | 13.1M |
| 股東權益 | 173M | −137M | 23.0M | 27.3M | 32.0M | 38.4M | 45.8M | 52.2M | 58.5M | 71.0M | 79.2M | 94.9M |
| 負債比 | 5.1% | 6.9% | 16.6% | 14.1% | 16.4% | 15.4% | 14.0% | 12.7% | 12.3% | 13.1% | 11.6% | 12.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −10.7M | – | – | −7.1M-7% | – | – | – | −7.6M | – | – | −11.7M |
| 資本支出 | – | 6K | – | – | 0.00 | – | – | – | 37K | – | – | 151K |
| 自由現金流 | – | −10.7M | – | – | −7.1M-7% | – | – | – | −7.7M | – | – | −11.9M |
| 折舊攤銷 | – | 29K | – | – | 30K | 139K | 140K | 135K | 137K | 137K | 138K | 161K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −21.1M | –% | -16.72 | −20.5M |
| FY2024 | – | – | −30.2M | –% | -24.01 | −24.8M |
| FY2023 | – | – | −34.1M | –% | -1.22 | −32.2M |
| FY2022 | – | – | −48.6M | –% | -1.58 | −39.3M |
| FY2021 | – | – | −36.8M | –% | -1.33 | −32.3M |
| FY2020 | – | – | −20.1M | –% | -12.53 | −18.9M |